eScholarship
metadata only
The cholinergic anti‐inflammatory pathway revisited
Inflammatory bowel disease negatively affects the quality of life of millions of patients around the world. Although the precise etiology of the disease remains elusive, aberrant immune system activation is an underlying cause. As such, therapies that selectively inhibit immune cell activation witho
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Immune-Lymphatic Interactions in Inflammatory Bowel Disease#294896
- IL1B-centered immune dysregulation involving IL7R, CCR7, ITGB2 and IRF1 across insomnia and inflammatory bowel disease.#975477
- Colon-targeted doxycycline-procaine azo mutual prodrug attenuates acetic-acid-induced ulcerative colitis in mice via modulation of CRP, IL-6, IL-10, and TNF-α#667777
- Precision medicine in the era of artificial intelligence: implications in chronic disease management#964412
- Cross Sectional Study of Vaccine Antibody Response in Inflammatory Bowel Disease Patients#1321141
Record · ID 1311362
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive